Blossomhill Therapeutics, Inc. · NASDAQ:BLSM
Cormorant Private Healthcare Fund VI, LP bought 312,500 Blossomhill Therapeutics, Inc. shares (Form 4)
Traded Aug 10, 2026 · Filed Aug 10, 2026
On Aug 10, 2026, Cormorant Private Healthcare Fund VI, LP (10% owner) bought 312,500 Blossomhill Therapeutics, Inc. shares at US$16.00 for US$5M, leaving 3,614,034 shares. Filed Aug 10, 2026 (Form 4).
- Bought
- 312,500 shares
- Price
- US$16.00
- Value
- US$5M
- Holding after
- 3,614,034 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | Common Stock | Conversion | 1,599,993 | 1,599,993 | Indirect | |
| Aug 10, 2026 | Common Stock | Conversion | 1,701,541 | 3,301,534 | Indirect | |
| Aug 10, 2026 | Common Stock | Buy | 312,500 | US$16.00 | 3,614,034 | Indirect |
Source
Related
- Blossomhill Therapeutics, Inc.
- Cormorant Private Healthcare Fund VI, LP
- Blossomhill Therapeutics, Inc. shareholders
- Schedule 13D · Orbimed Advisors LLC · Aug 18, 2026
- Schedule 13G · Vivo Innovation Fund II Holdings, L.P. · Aug 17, 2026
- Schedule 13G · Perceptive Advisors LLC · Aug 14, 2026
- Schedule 13D · Chen Bihua · Aug 13, 2026
- Form 4 · Gordon Carl L · Aug 12, 2026